Literature DB >> 30579145

Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease.

Denis S Smirnov1, Douglas Galasko2, Lawrence A Hansen3, Steven D Edland4, James B Brewer5, David P Salmon6.   

Abstract

Hippocampal sclerosis (HS) is a prevalent cause of dementia in the oldest old but is generally misdiagnosed as Alzheimer's disease (AD) due to similarities in clinical presentation. To determine if clinical and cognitive features diverge over time, we compared results from longitudinal evaluations of participants in the University of California, San Diego, Alzheimer's Disease Research Center with autopsy-confirmed AD (n = 195), HS (n = 21), or both HS + AD (n = 18). Each group exhibited decline in all cognitive measures, with HS declining at a slower rate than AD on the Mini-Mental State Examination, immediate recall condition of a word-list learning test, and Dementia Rating Scale total and subtest scores (except memory). Five years before the final evaluation, more prominent semantic and visuospatial deficits were apparent in AD participants than in HS participants despite comparable global cognitive impairment. Groups did not differ on any measure of executive function. HS + AD differed from AD only on the Boston Naming Test. Overall, results suggest that HS dementia is associated with cognitive deficits that progress more slowly than, but generally mimic, those observed in AD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognitive decline; Hippocampal Sclerosis; Longitudinal; Neuropsychology

Mesh:

Year:  2018        PMID: 30579145      PMCID: PMC6492933          DOI: 10.1016/j.neurobiolaging.2018.11.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

1.  Sodium tanshinone IIA sulfonate protects against Aβ-induced cell toxicity through regulating Aβ process.

Authors:  Da-Peng Zhang; Xin-Yi Lu; Si-Chen He; Wan-Yan Li; Ran Ao; Feona Chung-Yin Leung; Zhi-Min Zhang; Qu-Bo Chen; Shi-Jie Zhang
Journal:  J Cell Mol Med       Date:  2020-01-27       Impact factor: 5.310

2.  Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.

Authors:  Denis S Smirnov; Nicholas J Ashton; Kaj Blennow; Henrik Zetterberg; Joel Simrén; Juan Lantero-Rodriguez; Thomas K Karikari; Annie Hiniker; Robert A Rissman; David P Salmon; Douglas Galasko
Journal:  Acta Neuropathol       Date:  2022-02-23       Impact factor: 15.887

3.  Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.

Authors:  Denis S Smirnov; Douglas Galasko; Annie Hiniker; Steven D Edland; David P Salmon
Journal:  Neurology       Date:  2021-03-15       Impact factor: 11.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.